Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of therapeutic effect of compound Danshen dripping pills in the treatment of stable exertional angina pectoris.

X
Trial Profile

Evaluation of therapeutic effect of compound Danshen dripping pills in the treatment of stable exertional angina pectoris.

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Dec 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs T 89 (Primary) ; Aspirin
  • Indications Angina pectoris
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Dec 2017 Planned number of patients changed from 120 to 60.
    • 24 Dec 2017 Status changed from not yet recruiting to recruiting.
    • 23 Sep 2017 Planned number of patients changed from 60 to 120.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top